摘要：【中文】本公开总体上涉及真核起始因子2B调节剂或其药学上可接受的盐、立体异构体、立体异构体的混合物或前药，以及它们的制备和使用方法。 【EN】The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or pharmaceutically acceptable salts, stereoisomers, mixtures of stereoisomers, or prodrugs thereof, and methods of making and using the same.

摘要：【中文】本公开一般涉及化合物和组合物、中间体、它们的制备方法及它们作为激酶抑制剂的用途。 【EN】The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

摘要：【中文】本公开一般涉及用于预防或阻止细胞死亡和/或炎症的方法和组合物。 【EN】The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

摘要：【中文】本公开总体上涉及真核起始因子2B调节剂或其药学上可接受的盐、立体异构体、立体异构体的混合物或前药，以及其制备和使用方法。 【EN】The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or pharmaceutically acceptable salts, stereoisomers, mixtures of stereoisomers, or prodrugs thereof, and methods of making and using the same.